Marta Ferran
Barcelona, CT 08003, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).
Journal: Pharmacy (Basel, Switzerland)
Published: February 14, 2026
Ixekizumab optimization in moderate-to-severe plaque psoriasis in real clinical practice: a retrospective multicenter study.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: July 10, 2025
Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules: BIOBADADERM registry.
Journal: The Journal of investigative dermatology
Published: June 18, 2025
Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities.
Journal: International journal of molecular sciences
Published: April 07, 2025
Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin.
Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin.
Journal: Frontiers in immunology
Published: March 25, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 13, 2024
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 21, 2024
Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients.
Journal: International journal of molecular sciences
Published: July 09, 2024
Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicenter study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 18, 2024
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.
Journal: International journal of dermatology
Published: January 24, 2024
Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients.
Journal: Actas dermo-sifiliograficas
Published: September 24, 2023
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 03, 2023
Last Updated: 09/26/2026